Farms.com Home   News

Palmer Amaranth Discovered In RM Of Dufferin

An unwanted pigweed species known as Palmer amaranth has been found in the RM of Dufferin.

Kim Brown-Livingston is the province's weed specialist.

"A couple weeks ago, an agronomist had called and suspected that she'd found some Palmer amaranth in a bean field," she said. "Samples were sent in to the Pest Surveillance Initiative lab in Winnipeg, which is run by the Manitoba Canola Growers and we got a positive DNA confirmation that it definitely was Palmer amaranth."

Brown-Livingston believes this is the first case of Palmer amaranth found in Manitoba, although there were some suspected plants found in the past.

The concern with Palmer amaranth, and waterhemp (which has also been discovered in the RM of Dufferin), is that they are very invasive and can cause a lot of yield damage. They can also develop herbicide resistance very quickly.

Brown-Livingston says she's not sure how Palmer amaranth arrived in Manitoba, adding they may never know. She says, to her knowledge, this is the first case in Canada, although it is prevalent across the border in the U.S.

The weed was destroyed and had not yet gone to seed.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.